ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Proceeds from issuance of term debt, net

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥545.1B
P/E ratio
15.1x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndProceeds from issuance of term debt, net (Million JPY)YoY (%)
Mar 31, 20261,847-87.61%
Mar 31, 202514,908+828.85%
Mar 31, 20241,605+629.55%
Mar 31, 2023220-97.67%
Mar 31, 20229,450+227.78%
Mar 31, 20212,883-42.71%
Mar 31, 20205,032+4882.18%
Mar 31, 2019101-82.91%
Mar 31, 2018591-47.37%
Mar 31, 20171,123+69.89%
Mar 31, 2016661+548.04%
Mar 31, 2015102

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat